EPINEPHrine, 2 mg per 250 mL (8 mcg per mL) in 0.9% Sodium Chloride Injection, Rx only, SterRx, 1...

FDA Recall #D-0304-2022 — Class II — November 12, 2021

Recall #D-0304-2022 Date: November 12, 2021 Classification: Class II Status: Terminated

Product Description

EPINEPHrine, 2 mg per 250 mL (8 mcg per mL) in 0.9% Sodium Chloride Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY, 12903, NDC 70324-027-01.

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

SterRx, LLC — Plattsburgh, NY

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

2779 bags

Distribution

U.S.A. Nationwide

Code Information

S21257/BXC

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated